BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hel Z, Huijbregts RP, Xu J, Nechvatalova J, Vlkova M, Litzman J. Altered serum cytokine signature in common variable immunodeficiency. J Clin Immunol 2014;34:971-8. [PMID: 25246148 DOI: 10.1007/s10875-014-0099-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Stuchlý J, Kanderová V, Vlková M, Heřmanová I, Slámová L, Pelák O, Taraldsrud E, Jílek D, Králíc Ková P, Fevang B, Trková M, Hrušák O, Froňková E, Šedivá A, Litzman J, Kalina T. Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia. Sci Rep 2017;7:39710. [PMID: 28054583 DOI: 10.1038/srep39710] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
2 Simón-Fuentes M, Sánchez-Ramón S, Fernández-Paredes L, Alonso B, Guevara-Hoyer K, Vega MA, Corbí AL, Domínguez-Soto Á. Intravenous Immunoglobulins Promote an Expansion of Monocytic Myeloid-Derived Suppressor Cells (MDSC) in CVID Patients. J Clin Immunol 2022. [PMID: 35486340 DOI: 10.1007/s10875-022-01277-7] [Reference Citation Analysis]
3 Azizi G, Bagheri Y, Yazdani R, Zaki-Dizaji M, Jamee M, Jadidi-Niaragh F, Kamali AN, Abolhassani H, Aghamohammadi A. The profile of IL-4, IL-5, IL-10 and GATA3 in patients with LRBA deficiency and CVID with no known monogenic disease: Association with disease severity. Allergol Immunopathol (Madr) 2019;47:172-8. [PMID: 30193889 DOI: 10.1016/j.aller.2018.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Azizi G, Hafezi N, Mohammadi H, Yazdani R, Alinia T, Tavakol M, Aghamohammadi A, Mirshafiey A. Abnormality of regulatory T cells in common variable immunodeficiency. Cellular Immunology 2017;315:11-7. [DOI: 10.1016/j.cellimm.2016.12.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
5 Berbers RM, Drylewicz J, Ellerbroek PM, van Montfrans JM, Dalm VASH, van Hagen PM, Keller B, Warnatz K, van de Ven A, van Laar JM, Nierkens S, Leavis HL. Targeted Proteomics Reveals Inflammatory Pathways that Classify Immune Dysregulation in Common Variable Immunodeficiency. J Clin Immunol 2021;41:362-73. [PMID: 33190167 DOI: 10.1007/s10875-020-00908-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Moritz CP, Paul S, Stoevesandt O, Tholance Y, Camdessanché J, Antoine J. Autoantigenomics: Holistic characterization of autoantigen repertoires for a better understanding of autoimmune diseases. Autoimmunity Reviews 2020;19:102450. [DOI: 10.1016/j.autrev.2019.102450] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
7 Lollo C, de Moraes Vasconcelos D, Oliveira LMDS, Domingues R, Carvalho GC, Duarte AJDS, Sato MN. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency. Clin Immunol 2016;169:121-7. [PMID: 27392462 DOI: 10.1016/j.clim.2016.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Lattanzi B, Baroncelli S, De Santis A, Galluzzo CM, Mennini G, Michelini Z, Lupo M, Ginanni Corradini S, Rossi M, Palmisano L, Merli M. Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients. Aliment Pharmacol Ther 2018;48:1146-55. [PMID: 30294870 DOI: 10.1111/apt.14994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pecoraro A, Crescenzi L, Varricchi G, Marone G, Spadaro G. Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders. Front Immunol 2020;11:338. [PMID: 32184784 DOI: 10.3389/fimmu.2020.00338] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hultberg J, Ernerudh J, Larsson M, Nilsdotter-Augustinsson Å, Nyström S. Plasma protein profiling reflects TH1-driven immune dysregulation in common variable immunodeficiency. J Allergy Clin Immunol 2020;146:417-28. [PMID: 32057767 DOI: 10.1016/j.jaci.2020.01.046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Polito R, Nigro E, Pecoraro A, Monaco ML, Perna F, Sanduzzi A, Genovese A, Spadaro G, Daniele A. Adiponectin Receptors and Pro-inflammatory Cytokines Are Modulated in Common Variable Immunodeficiency Patients: Correlation With Ig Replacement Therapy. Front Immunol 2019;10:2812. [PMID: 31827477 DOI: 10.3389/fimmu.2019.02812] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Pecoraro A, Crescenzi L, Galdiero MR, Marone G, Rivellese F, Rossi FW, de Paulis A, Genovese A, Spadaro G. Immunosuppressive therapy with rituximab in common variable immunodeficiency. Clin Mol Allergy 2019;17:9. [PMID: 31080365 DOI: 10.1186/s12948-019-0113-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
13 Litzman J, Chovancová Z, Bejdák P, Litzman M, Hel Z, Vlková M. Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase. Int J Immunopathol Pharmacol 2019;33:2058738419843381. [PMID: 30968712 DOI: 10.1177/2058738419843381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Macpherson ME, Halvorsen B, Yndestad A, Ueland T, Mollnes TE, Berge RK, Rashidi A, Otterdal K, Gregersen I, Kong XY, Holven KB, Aukrust P, Fevang B, Jørgensen SF. Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency. Sci Rep 2019;9:9427. [PMID: 31263122 DOI: 10.1038/s41598-019-45861-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
15 Callery EL, Morais CLM, Paraskevaidi M, Brusic V, Vijayadurai P, Anantharachagan A, Martin FL, Rowbottom AW. New approach to investigate Common Variable Immunodeficiency patients using spectrochemical analysis of blood. Sci Rep 2019;9:7239. [PMID: 31076587 DOI: 10.1038/s41598-019-43196-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
16 Barsotti NS, Almeida RR, Costa PR, Barros MT, Kalil J, Kokron CM. IL-10-Producing Regulatory B Cells Are Decreased in Patients with Common Variable Immunodeficiency. PLoS One 2016;11:e0151761. [PMID: 26991898 DOI: 10.1371/journal.pone.0151761] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
17 van Stigt AC, Dalm VASH, Nagtzaam NMA, van Rijswijk DA, Barendregt BH, van Hagen PM, IJspeert H, Dik WA. Soluble Interleukin-2 Receptor Is a Promising Serum Biomarker for Granulomatous Disease in Common Variable Immune Deficiency. J Clin Immunol 2021;41:694-7. [PMID: 33404971 DOI: 10.1007/s10875-020-00947-8] [Reference Citation Analysis]
18 Vlkova M, Chovancova Z, Nechvatalova J, Connelly AN, Davis MD, Slanina P, Travnickova L, Litzman M, Grymova T, Soucek P, Freiberger T, Litzman J, Hel Z. Neutrophil and Granulocytic Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression Significantly Contributes to Immune Dysregulation in Common Variable Immunodeficiency Disorders. J Immunol 2019;202:93-104. [PMID: 30487174 DOI: 10.4049/jimmunol.1800102] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
19 Paquin-Proulx D, Sandberg JK. Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression. Front Immunol 2014;5:637. [PMID: 25566250 DOI: 10.3389/fimmu.2014.00637] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
20 de Lollo C, de Moraes Vasconcelos D, da Silva Oliveira LM, de Oliveira Titz T, Carneiro-Sampaio M, Jacob CM, da Silva Duarte AJ, Sato MN. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency. J Transl Med 2016;14:138. [PMID: 27188997 DOI: 10.1186/s12967-016-0900-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
21 Dupin C, Marchand-Adam S, Favelle O, Costes R, Gatault P, Diot P, Grammatico-Guillon L, Guilleminault L. Asthma and Hypogammaglobulinemia: an Asthma Phenotype with Low Type 2 Inflammation. J Clin Immunol 2016;36:810-7. [PMID: 27714565 DOI: 10.1007/s10875-016-0335-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
22 Berbers R, Nierkens S, van Laar JM, Bogaert D, Leavis HL. Microbial Dysbiosis in Common Variable Immune Deficiencies: Evidence, Causes, and Consequences. Trends in Immunology 2017;38:206-16. [DOI: 10.1016/j.it.2016.11.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
23 Pecoraro A, Nigro E, Polito R, Monaco ML, Scudiero O, Mormile I, Cesoni Marcelli A, Capasso M, Habetswallner F, Genovese A, Daniele A, Spadaro G. Total and High Molecular Weight Adiponectin Expression Is Decreased in Patients with Common Variable Immunodeficiency: Correlation with Ig Replacement Therapy. Front Immunol 2017;8:895. [PMID: 28824624 DOI: 10.3389/fimmu.2017.00895] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
24 Amaya-Uribe L, Rojas M, Azizi G, Anaya JM, Gershwin ME. Primary immunodeficiency and autoimmunity: A comprehensive review. J Autoimmun 2019;99:52-72. [PMID: 30795880 DOI: 10.1016/j.jaut.2019.01.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
25 Kotlinowski J, Bukowska-Strakova K, Koppolu A, Kosińska J, Pydyn N, Stawinski P, Wilamowski M, Nowak W, Józkowicz A, Baran J, Płoski R, Jura J. A Novel Monoallelic Nonsense Mutation in the NFKB2 Gene Does Not Cause a Clinical Manifestation. Front Genet 2019;10:140. [PMID: 30863427 DOI: 10.3389/fgene.2019.00140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]